Stocks VSTS Financial statements
Financial statementsVestis Corp financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Vestis Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 2,687 | 2,825 | 2,806 | 2,735 |
| Cost of revenue | 1,910 | 1,970 | 1,990 | 2,010 |
| Gross profit | 777 | 855 | 816 | 725 |
| Selling, general and administrative | 451 | 501 | 517 | 517 |
| Operating income | 192 | 218 | 158 | 64.4 |
| Interest expense | 4.55 | 2.11 | 127 | 93.6 |
| Other non-operating income | -2.26 | 2.1 | 0.64 | -13.7 |
| Pre-tax income | 190 | 270 | 32 | -44.3 |
| Income tax | 48.3 | 56.6 | 11.1 | -4.08 |
| Net income | 142 | 213 | 21 | -40.2 |
| EBITDA | 327 | 354 | 299 | 207 |
| EPS, basic | 1.08 | 1.63 | 0.16 | -0.31 |
| EPS, diluted | 1.08 | 1.63 | 0.16 | -0.31 |
| Shares, basic (weighted) | 131 | 131 | 132 | 132 |
| Shares, diluted (weighted) | 131 | 131 | 132 | 132 |
| Dividend per share | 0.04 | 0.04 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 23.7 | 36.1 | 31 | 29.7 |
| Receivables | 393 | 177 | 162 | |
| Inventory | 175 | 165 | 179 | |
| Other current assets | 17.2 | 44 | 73.3 | |
| Total current assets | 1,020 | 813 | 850 | |
| Property, plant and equipment | 665 | 671 | 663 | |
| Lease right-of-use assets | 57.9 | 73.5 | 85.1 | |
| Goodwill | 963 | 964 | 964 | 962 |
| Intangible assets | 239 | 239 | 213 | 189 |
| Other non-current assets | 213 | 198 | 158 | |
| Total assets | 3,157 | 2,932 | 2,907 | |
| Accounts payable | 134 | 163 | 158 | |
| Accrued liabilities | 73.4 | 145 | 101 | |
| Short-term debt | 26.3 | 0 | 0 | |
| Total current liabilities | 396 | 456 | 409 | |
| Long-term debt | 1,463 | 1,148 | 1,155 | |
| Lease liabilities | 46.1 | 66.1 | 77 | |
| Other non-current liabilities | 52.6 | 52.6 | 91.7 | |
| Total liabilities | 2,280 | 2,029 | 2,041 | |
| Total debt | 1,489 | 1,163 | 1,169 | |
| Paid-in capital | 0 | 928 | 938 | |
| Retained earnings | 0 | 2.57 | -46.9 | |
| Other comprehensive income | -31.2 | -28.9 | -26.3 | |
| Shareholders' equity | 2,336 | 877 | 903 | 866 |
| Total equity | 2,336 | 877 | 903 | 866 |
| Total liabilities and equity | 3,157 | 2,932 | 2,907 | |
| Shares outstanding | 131 | 132 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 142 | 213 | 21 | -40.2 |
| Depreciation and amortization | 134 | 137 | 141 | 143 |
| Stock-based compensation | 17.4 | 14.5 | 16.3 | 11.6 |
| Deferred income tax | 20.6 | 14.4 | -19.6 | -13.4 |
| Change in receivables | -53.9 | -23.6 | 216 | 14 |
| Change in inventory | -0.63 | 8.93 | 9.87 | -13.7 |
| Change in payables | 31.4 | -32.9 | 21.7 | -0.27 |
| Cash from operations | 233 | 257 | 472 | 64.2 |
| Capital expenditures | -76.4 | -77.9 | -78.9 | -58.5 |
| Acquisitions | -17.2 | 0 | 0 | |
| Cash from investing | -86.1 | -14.7 | -73.6 | -19.8 |
| Debt issued | 0 | 1,500 | 798 | 167 |
| Debt repaid | 0 | 0 | -1,138 | -161 |
| Stock issued | 0.1 | 0 | ||
| Dividends paid | 0 | 0 | -13.8 | -13.8 |
| Cash from financing | -163 | -230 | -403 | -46.1 |
| Net change in cash | -17.4 | 12.3 | -5.04 | -1.26 |
| Free cash flow | 156 | 179 | 393 | 5.77 |
| Income taxes paid | 3.5 | 0.2 | 19.1 | 26.5 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 26.3% | Gross profit / revenue. |
| Operating margin | 3.6% | Operating income / revenue. |
| EBITDA margin | 8.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -0.1% | Pre-tax income / revenue. |
| Net margin | -0.2% | Net income / revenue. |
| FCF margin | 5.1% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 7.1% | Cash from operations / revenue. |
| Return on equity (ROE) | -0.6% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -0.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | 4.1% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 17.6% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.4% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.1% | Capital expenditures / revenue. |
| D&A / revenue | 5.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -2.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 0.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -11.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -2.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | -59.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -30.5% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -30.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -14.0% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -291.8% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -293.8% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -86.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -34.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -98.5% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -66.7% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 0.0% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | -4.1% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -28.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -0.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Share count change, 1y | -0.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.17x | Current assets / current liabilities. |
| Quick ratio | 0.52x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.15x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 1.24x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 38.4% | Total debt / total assets. |
| Liabilities / assets | 69.0% | Total liabilities / total assets. |
| Net debt | $1.03B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 4.36x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $447.7M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 39.9% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$251.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.95x | Revenue / average total assets. |
| Fixed asset turnover | 4.19x | Revenue / average property, plant and equipment. |
| Inventory turnover | 12.5x | Cost of revenue / average inventory. |
| Days inventory | 29 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 18.9x | Revenue / average receivables. |
| Days sales outstanding | 19 days | 365 x average receivables / revenue. |
| Days payables | 24 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 25 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 28.9% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.04 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $20.07 | Revenue / diluted weighted shares. |
| FCF per share | $1.02 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.43 | Cash from operations / diluted weighted shares. |
| Book value per share | $6.64 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$1.90 | Tangible book value / shares outstanding. |
| Cash per share | $0.44 | (Cash + short-term investments) / shares outstanding. |
| Dividends / FCF | 0.0% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.80B | Share price x shares outstanding. |
| Enterprise value | $2.83B | Market cap + total debt - cash - short-term investments. |
| P/S | 0.67x | Market cap / revenue. |
| P/B | 2.06x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 13.2x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 9.41x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.05x | Enterprise value / revenue. |
| EV/EBIT | 28.8x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 12.0x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 20.8x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 7.6% | Free cash flow / market cap. |
| Earnings yield | -0.3% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.0% | Dividends paid over the period / market cap. |
| Shareholder yield | 0.0% | (Dividends paid + share buybacks) / market cap. |
What was Vestis Corp's revenue in fiscal 2025?
Vestis Corp reported revenue of $2.73B for fiscal 2025, 2.5% lower than the year before.
Was Vestis Corp profitable in fiscal 2025?
No. It reported a net loss of $40.2M.
How much free cash flow did Vestis Corp generate in fiscal 2025?
Cash from operations of $64.2M minus capital expenditures of $58.5M left free cash flow of $5.8M.